• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Expert review of precision medicine and drug development

    Expert review of precision medicine and drug development

    JournalISSN 2380-8993eISSN 2380-8993中科院 医学 4区

    年发文量

    研究主题

    论文(290)

    排序
    1Towards Precision Medicine for Systemic Lupus Erythematosus and Neuropsychiatric Manifestations.
    Bruna Martins de Aquino,Taίs Nitsch Mazzola,Paulo Rogério Julio, Rodrigo Marchi Silva, Samara Rosa Sepresse, Timothy Brett Niewold,Simone Appenzeller

    Introduction:Systemic lupus erythematosus (SLE) is a multisystem disease with a heterogenous pathophysiological mechanisms that lead to a variety of clinical, immunological, and neuropsychiatric manifestations. Areas covered:In this review, we will summarize the current understanding of molecular pathways involved in SLE and neuropsychiatric manifestations, focusing on genetic and epigenetic mechanisms and the implications of these findings in differences observed in treatment response. Expert opinion:Great progress has been made in understanding the heterogeneity in SLE, which may help direct therapy. However, neuropsychiatric manifestations still are a challenge in clinical practice, and future studies are needed to identify relevant diagnostic and prognostic biomarkers.

    2025
    引用
    AI阅读
    加入学术空间
    2Advances in Functional Radionuclide Imaging and Therapy for Individualized Management of Patients: the Growing Importance of Nuclear Theranostics in Precision Oncology Practice
    Parth Baberwal, Sandip Basu
    2025
    引用
    AI阅读
    加入学术空间
    3Immunotherapy for Precision Medicine in Colorectal Cancer.
    Miao Cao, Michael Xu, Zinah Bairmani,Babar Bashir,Scott A Waldman,Adam E Snook

    Introduction:Colorectal cancer (CRC) is the fourth most common cancer and second leading cause of cancer-related death in the United States. The implementation of CRC screening has decreased CRC incidence in adults older than 65 years. However, among young adults who experience more aggressive disease progression, CRC incidence has been increasing for decades. Immunotherapy represents a collection of innovative and promising approaches with greater efficacy and safety. In this review, we discuss modalities and selected targets of immunotherapies for CRCs that are guided by precision medicine. Areas covered:The following review focuses on immunological approaches for CRCs, including therapeutic monoclonal antibodies, immune checkpoint blockade, cancer vaccines, and adoptive cell therapies. Expert opinion:Metastatic and refractory CRCs are significant causes of cancer-related mortality and remain difficult to treat with current standard therapies. Following multiple FDA approvals for hematologic malignancies, research into solid tumor immunotherapies has substantially increased. Several chimeric antigen receptor (CAR)-expressing T cell therapies are showing promise in CRC. Moreover, immune checkpoint blocking antibodies are transforming care for a subset of CRC patients. With advances in our understanding of oncogenic mechanisms and development of novel treatment approaches, personalized immunotherapies are poised to dramatically change the landscape of CRC treatment.

    2025引用:1
    引用
    AI阅读
    加入学术空间
    4Challenges and Opportunities for Precision Medicine in Developing Nations
    Juan-Manuel Anaya, Maria Herran, Luis Eduardo Pino

    Introduction Precision medicine customizes prevention, diagnosis, and treatment based on individual characteristics. Despite advancements, significant challenges remain in the widespread implementation of precision medicine across low- to middle-income countries (LMICs) such as Colombia. This review aims to identify and propose possible solutions to help close this gap. Areas covered Implementing precision medicine in LMICs requires addressing key barriers such as limited technology, inadequate healthcare training, ethical considerations, insufficient insurance coverage, public attitudes, high costs, and lack of political support. Expert opinion Precision medicine has the potential to revolutionize patient care and healthcare practices. By addressing these challenges and prioritizing strategic development areas, LMICs can fully embrace it, leading to significant improvements in healthcare outcomes for their diverse populations.

    2025引用:5
    引用
    AI阅读
    加入学术空间
    5Drug Discovery in the Context of Precision Medicine and Artificial Intelligence
    Mandana Hasanzad,Marzieh Nosrati,Fatemeh Khatami,Parham Rahmani,Negar Sarhangi,Shekoufeh Nikfar,Mohammad Abdollahi

    Introduction The drug development process traditionally includes rigorous pre-clinical testing in laboratories and animal models to assess the safety, efficacy, pharmacokinetics, and toxicology of potential drug candidates before progressing to human clinical trials. Developing AI, machine ML algorithms, and PM approaches will facilitate identifying potential drug targets, predicting therapeutic outcomes, and optimizing the selection of lead compounds.

    2024引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 290 篇论文

    高被引作者

    作者引用发文
    Parekh Vishwa5812
    Michael A. Jacobs5812
    Bertalan Mesko2231
    Malgorzata Czystowska-Kuzmicz1621
    Laura Strauss1621
    Theresa L. Whiteside1621
    Magis Mandapathil1621
    Marta Szajnik1621
    Yujin Hoshida1092
    Alexander J Thompson771

    高产作者

    作者引用发文
    Alessandro Rizzo2910
    Francesco Massari279
    Rodolfo Montironi177
    Angela Dalia Ricci217
    Marina Scarpelli136
    Liang Cheng166
    Giovanni Brandi166
    Antonio Lopez-Beltran136
    Matteo Santoni105
    Alessia Cimadamore74

    相关期刊

    Bulletin du cancer
    Seminars in oncology
    Journal of immunotherapy (Hagerstown, Md. : 1997)
    Targeted oncology
    memo - Magazine of European Medical Oncology
    Clinical Medicine Insights: Oncology
    Cancer Journal
    Clinical advances in hematology & oncology
    Journal of Immunotherapy and Precision Oncology
    Precision Cancer Medicine